Remacade

Were you looking for information about Remicade? Remacade is a common misspelling of Remicade.
 
Remicade® (infliximab) is a prescription medication that is approved to treat certain inflammatory conditions, such as rheumatoid arthritis, ankylosing spondylitis, and plaque psoriasis. The drug is administered intravenously. Depending on the condition being treated, it is usually administered more frequently at the beginning of the treatment, followed by doses every six to eight weeks. Side effects of Remicade may include coughing, anemia, and infections.
 
(Click Remicade for more information on how the drug works, guidelines for when and how to take it, and potential overdose symptoms.)
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;